🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Today there are no tests that allow to make a precise differential diagnosi...
Status
Completed
Location
IRCCS/AUSL Reggio Emilia Hospital
Start Date
2017-11-03
Trial ID
NCT03346018
Treatments Being Tested
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
The main goal of this study is to evaluate the anti-relapse prophylactic ac...
Status
Completed
Location
Hospital Universitario de Cruces
Start Date
2016-05
Trial ID
NCT02763475
Treatments Being Tested
RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and tota...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2006-02
Trial ID
NCT00354172
This study will find the maximum tolerated dose (MTD) of CYNK-001 which con...
Status
Unknown
Location
Colorado Blood Cancer Institute
Start Date
2020-05-12
Trial ID
NCT04309084
Treatments Being Tested
The trial investigates the efficacy of adoptive immunotherapy with haploide...
Status
Terminated
Location
Klinikum Bayreuth
Start Date
2015-09
Trial ID
NCT02229266
Treatments Being Tested
This study is a Phase 1 / 2 trial to determine the safety and efficacy of C...
Status
Terminated
Location
UC Irvine
Start Date
2020-09-02
Trial ID
NCT04365101
Treatments Being Tested
Several reports have examined Programmed Death 1 (PD-1) expression on tumor...
Status
Unknown
Location
Instituto National de Cancerologia
Start Date
2017-03
Trial ID
NCT02758314
Treatments Being Tested
This study is being done to assess the safety and determine the maximum tol...
Status
Recruiting
Location
UW Carbone Cancer Center
Start Date
2026-02-26
Trial ID
NCT07285668
Treatments Being Tested
This is a phase I/II study of highly selected donor lymphocyte infusions in...
Status
Completed
Location
Universitätsklinikum
Start Date
2004-01
Trial ID
NCT01386619
Treatments Being Tested